HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chandan K Sen Selected Research

Triacetoneamine-N-Oxyl (Tempone)

2/2008Assessment of wound-site redox environment and the significance of Rac2 in cutaneous healing.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chandan K Sen Research Topics

Disease

75Wounds and Injuries (Trauma)
06/2022 - 05/2002
25Inflammation (Inflammations)
01/2022 - 06/2002
19Neoplasms (Cancer)
11/2019 - 05/2002
15Infections
12/2021 - 06/2003
13Stroke (Strokes)
01/2020 - 10/2005
12Hypoxia (Hypoxemia)
01/2017 - 05/2002
11Infarction (Infarctions)
11/2019 - 05/2006
9Ischemia
01/2022 - 05/2006
7Ischemic Stroke
01/2021 - 07/2010
6Hyperoxia
09/2010 - 02/2003
5Burns
10/2018 - 01/2015
5Obesity
08/2012 - 01/2004
4Wound Infection (Wound Infections)
10/2021 - 09/2002
4Hemangioendothelioma
10/2017 - 10/2004
4Myocardial Infarction
04/2009 - 02/2003
3COVID-19
01/2021 - 10/2020
3Atherosclerosis
11/2010 - 02/2003
3Sudden Infant Death (SID)
04/2007 - 08/2004
3Body Weight (Weight, Body)
01/2006 - 02/2003
2Ulcer
06/2022 - 01/2018
2Sepsis (Septicemia)
01/2022 - 03/2020
2Lymphedema (Milroy Disease)
01/2022 - 10/2021
2Hemangioma (Angioma)
10/2021 - 06/2017
2Reperfusion Injury
11/2019 - 09/2010
2Hyperglycemia
11/2019 - 12/2017
2Cicatrix (Scar)
01/2017 - 09/2015
2Hypertrophy
01/2013 - 02/2003
2Skin Diseases (Skin Disease)
01/2013 - 05/2011
2Cardiomyopathies (Cardiomyopathy)
01/2013 - 02/2003
2Weight Loss (Weight Reduction)
08/2012 - 12/2009
2Cardiovascular Diseases (Cardiovascular Disease)
12/2010 - 02/2003
2Heart Failure
12/2008 - 02/2003

Drug/Important Bio-Agent (IBA)

20Oxygen (Dioxygen)IBA
06/2022 - 05/2002
18MicroRNAs (MicroRNA)IBA
01/2019 - 04/2007
13Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 05/2002
11Proteins (Proteins, Gene)FDA Link
10/2020 - 08/2004
9Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 09/2002
9CollagenIBA
05/2021 - 02/2009
8Anti-Bacterial Agents (Antibiotics)IBA
12/2021 - 01/2013
8Vitamin EFDA LinkGeneric
01/2020 - 12/2004
8CytokinesIBA
01/2020 - 05/2005
8Biological ProductsIBA
01/2019 - 06/2006
7TocotrienolsIBA
01/2020 - 03/2006
7Oxidants (Oxidizing Agents)IBA
05/2016 - 09/2002
6DNA (Deoxyribonucleic Acid)IBA
01/2022 - 04/2007
6Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2011 - 05/2002
5Biomarkers (Surrogate Marker)IBA
01/2022 - 02/2003
5EnzymesIBA
05/2021 - 09/2003
4RNA (Ribonucleic Acid)IBA
01/2022 - 01/2005
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2020 - 04/2005
4Messenger RNA (mRNA)IBA
01/2019 - 04/2007
4NF-kappa B (NF-kB)IBA
01/2019 - 07/2005
4Glutamic Acid (Glutamate)FDA Link
10/2017 - 10/2005
4Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
09/2015 - 06/2003
4Tocopherols (Tocopherol)IBA
03/2015 - 03/2006
3LipidsIBA
10/2021 - 10/2008
3PolymersIBA
01/2021 - 08/2012
3Interleukin-10 (Interleukin 10)IBA
10/2019 - 01/2012
3NADPH Oxidases (NAD(P)H oxidase)IBA
10/2017 - 09/2002
3Transforming Growth Factor beta (TGF-beta)IBA
01/2017 - 04/2007
3ChemokinesIBA
07/2010 - 10/2004
3Plant ExtractsIBA
09/2007 - 01/2004
34-hydroxy-2-nonenal (4-hydroxynonenal)IBA
04/2007 - 10/2002
3Streptozocin (Streptozotocin)FDA Link
04/2007 - 08/2004
3Free RadicalsIBA
09/2003 - 05/2002
2MethyltransferasesIBA
01/2022 - 01/2019
2Trinitrotoluene (TNT)IBA
01/2022 - 10/2020
2Oncostatin MIBA
01/2022 - 09/2012
2Indocyanine Green (Cardio-Green)FDA LinkGeneric
10/2021 - 09/2016
2Surface-Active Agents (Surfactants)IBA
01/2021 - 01/2018
2AntioxidantsIBA
10/2020 - 04/2007
2Interleukin-4 (Interleukin 4)IBA
10/2019 - 01/2012
2SilverIBA
01/2019 - 01/2015
2locked nucleic acidIBA
01/2018 - 04/2009
2HydrogelsIBA
01/2018 - 12/2009
2CatalaseIBA
01/2018 - 01/2006
2Lipid NanoparticlesIBA
01/2018 - 10/2016
2Transaminases (Aminotransferases)IBA
10/2017 - 01/2017
2multidrug resistance-associated protein 1IBA
10/2017 - 08/2011
2Oxaloacetic Acid (Oxalacetic Acid)IBA
10/2017 - 01/2017
2Neuroprotective AgentsIBA
10/2017 - 11/2011
2Adenosine Triphosphate (ATP)IBA
01/2017 - 10/2016
2Collagen Type I (Type I Collagen)IBA
11/2014 - 05/2013
2Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
03/2014 - 10/2002
2Glutathione (Reduced Glutathione)IBA
08/2013 - 10/2002
2Polyvinyl AlcoholIBA
09/2012 - 05/2011
2Heat-Shock Proteins (Heat-Shock Protein)IBA
12/2010 - 04/2007
2GadoliniumIBA
11/2010 - 11/2009
2Pharmaceutical PreparationsIBA
06/2009 - 05/2002
2Phosphoric Monoester Hydrolases (Phosphatases)IBA
06/2009 - 04/2009
2TensinsIBA
06/2009 - 04/2009
2CholesterolIBA
10/2008 - 03/2006
2Hematoxylin (Haematoxylon)IBA
09/2008 - 06/2008
2Eosine Yellowish-(YS) (Eosin)IBA
09/2008 - 06/2008
2Glucose (Dextrose)FDA LinkGeneric
04/2007 - 08/2004

Therapy/Procedure

26Therapeutics
06/2022 - 05/2002
17Lasers (Laser)
10/2021 - 05/2006
3Surgical Amputation (Amputations)
10/2021 - 01/2009
2Debridement
01/2018 - 01/2013
2Oral Administration
01/2009 - 01/2006